Loading
A phase 3 trial of Thermal ablation in Breast cancer, run by Franciscus Gasthuis & Vlietland (Hospital), not yet recruiting.
Cryoablation Versus Lumpectomy in Early-Stage Breast Cancer is a phase 3 interventional study registered as NCT07483996 by Franciscus Gasthuis & Vlietland (Hospital), with 938 participants planned, started 2026-04-01 and due to reach its primary completion in 2035-12-31. Interventions recorded: Percutaneous cryoablation, Breast-conserving surgery. Conditions recorded: Early-Stage Breast Cancer.
Linked to the technology Thermal ablation because the registry names it ("thermal ablation") among its interventions and Breast cancer among its conditions. Registry record only: no result has been read by an editor.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Thermal ablation (RFA, microwave, cryo) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/